Tidal Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.02M Buy
51,399
+3,495
+7% +$273K 0.02% 473
2025
Q1
$3.47M Buy
47,904
+934
+2% +$67.7K 0.03% 480
2024
Q4
$3.48M Buy
46,970
+7,438
+19% +$551K 0.03% 487
2024
Q3
$2.61M Buy
39,532
+275
+0.7% +$18.1K 0.03% 512
2024
Q2
$3.63M Buy
39,257
+9,012
+30% +$832K 0.05% 328
2024
Q1
$2.89M Buy
30,245
+10,700
+55% +$1.02M 0.05% 382
2023
Q4
$1.49M Buy
19,545
+1,291
+7% +$98.4K 0.03% 463
2023
Q3
$1.26M Buy
18,254
+2,909
+19% +$202K 0.04% 471
2023
Q2
$1.45M Sell
15,345
-244
-2% -$23K 0.04% 416
2023
Q1
$1.29M Buy
15,589
+1,059
+7% +$87.6K 0.04% 403
2022
Q4
$1.08M Buy
14,530
+1,179
+9% +$88K 0.04% 419
2022
Q3
$1.1M Buy
13,351
+698
+6% +$57.7K 0.05% 346
2022
Q2
$1.2M Buy
12,653
+159
+1% +$15.1K 0.04% 338
2022
Q1
$1.47M Buy
12,494
+1,553
+14% +$183K 0.04% 317
2021
Q4
$1.42M Buy
10,941
+1,894
+21% +$245K 0.04% 309
2021
Q3
$1.02M Buy
9,047
+1,397
+18% +$158K 0.04% 328
2021
Q2
$792K Buy
7,650
+2,396
+46% +$248K 0.03% 339
2021
Q1
$439K Buy
5,254
+1,048
+25% +$87.6K 0.02% 326
2020
Q4
$384K Buy
4,206
+747
+22% +$68.2K 0.03% 267
2020
Q3
$276K Buy
3,459
+417
+14% +$33.3K 0.04% 202
2020
Q2
$210K Buy
+3,042
New +$210K 0.03% 281